Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial.
Mediterranean diet
arginine catabolism metabolites
atrial fibrillation
case-control
heart failure
metabolomics
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
02 09 2022
02 09 2022
Historique:
received:
10
01
2022
revised:
25
04
2022
accepted:
11
05
2022
pubmed:
17
5
2022
medline:
9
9
2022
entrez:
16
5
2022
Statut:
ppublish
Résumé
Arginine-derived metabolites are involved in oxidative and inflammatory processes related to endothelial functions and cardiovascular risks. We prospectively examined the associations of arginine catabolism metabolites with the risks of atrial fibrillation (AF) or heart failure (HF), and evaluated the potential modifications of these associations through Mediterranean diet (MedDiet) interventions in a large, primary-prevention trial. Two nested, matched, case-control studies were designed within the Prevención con Dieta Mediterránea (PREDIMED) trial. We selected 509 incident cases and 547 matched controls for the AF case-control study and 326 cases and 402 matched controls for the HF case-control study using incidence density sampling. Fasting blood samples were collected at baseline and arginine catabolism metabolites were measured using LC-tandem MS. Multivariable conditional logistic regression models were applied to test the associations between the metabolites and incident AF or HF. Interactions between metabolites and intervention groups (MedDiet groups compared with control group) were analyzed with the likelihood ratio test. Inverse association with incident AF was observed for arginine (OR per 1 SD, 0.83; 95% CI: 0.73-0.94), whereas a positive association was found for N1-acetylspermidine (OR for Q4 compared with Q1 1.58; 95% CI: 1.13-2.25). For HF, inverse associations were found for arginine (OR per 1 SD, 0.82; 95% CI: 0.69-0.97) and homoarginine (OR per 1 SD, 0.81; 95% CI: 0.68-0.96), and positive associations were found for the asymmetric dimethylarginine (ADMA) and symmetric dimethlyarginine (SDMA) ratio (OR per 1 SD, 1.19; 95% CI: 1.02-1.41), N1-acetylspermidine (OR per 1 SD, 1.34; 95% CI: 1.12-1.60), and diacetylspermine (OR per 1 SD, 1.20; 95% CI: 1.02-1.41). In the stratified analysis according to the dietary intervention, the lower HF risk associated with arginine was restricted to participants in the MedDiet groups (P-interaction = 0.044). Our results suggest that arginine catabolism metabolites could be involved in AF and HF. Interventions with the MedDiet may contribute to strengthen the inverse association between arginine and the risk of HF. This trial was registered at controlled-trials.com as ISRCTN35739639.
Sections du résumé
BACKGROUND
Arginine-derived metabolites are involved in oxidative and inflammatory processes related to endothelial functions and cardiovascular risks.
OBJECTIVES
We prospectively examined the associations of arginine catabolism metabolites with the risks of atrial fibrillation (AF) or heart failure (HF), and evaluated the potential modifications of these associations through Mediterranean diet (MedDiet) interventions in a large, primary-prevention trial.
METHODS
Two nested, matched, case-control studies were designed within the Prevención con Dieta Mediterránea (PREDIMED) trial. We selected 509 incident cases and 547 matched controls for the AF case-control study and 326 cases and 402 matched controls for the HF case-control study using incidence density sampling. Fasting blood samples were collected at baseline and arginine catabolism metabolites were measured using LC-tandem MS. Multivariable conditional logistic regression models were applied to test the associations between the metabolites and incident AF or HF. Interactions between metabolites and intervention groups (MedDiet groups compared with control group) were analyzed with the likelihood ratio test.
RESULTS
Inverse association with incident AF was observed for arginine (OR per 1 SD, 0.83; 95% CI: 0.73-0.94), whereas a positive association was found for N1-acetylspermidine (OR for Q4 compared with Q1 1.58; 95% CI: 1.13-2.25). For HF, inverse associations were found for arginine (OR per 1 SD, 0.82; 95% CI: 0.69-0.97) and homoarginine (OR per 1 SD, 0.81; 95% CI: 0.68-0.96), and positive associations were found for the asymmetric dimethylarginine (ADMA) and symmetric dimethlyarginine (SDMA) ratio (OR per 1 SD, 1.19; 95% CI: 1.02-1.41), N1-acetylspermidine (OR per 1 SD, 1.34; 95% CI: 1.12-1.60), and diacetylspermine (OR per 1 SD, 1.20; 95% CI: 1.02-1.41). In the stratified analysis according to the dietary intervention, the lower HF risk associated with arginine was restricted to participants in the MedDiet groups (P-interaction = 0.044).
CONCLUSIONS
Our results suggest that arginine catabolism metabolites could be involved in AF and HF. Interventions with the MedDiet may contribute to strengthen the inverse association between arginine and the risk of HF. This trial was registered at controlled-trials.com as ISRCTN35739639.
Identifiants
pubmed: 35575609
pii: S0002-9165(22)00082-X
doi: 10.1093/ajcn/nqac139
pmc: PMC9437981
doi:
Substances chimiques
Arginine
94ZLA3W45F
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-662Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118264
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
J Am Coll Cardiol. 2015 Apr 21;65(15):1509-20
pubmed: 25881932
Cardiol Clin. 2019 May;37(2):119-129
pubmed: 30926013
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):902-904
pubmed: 29684102
Nutrients. 2018 Jan 10;10(1):
pubmed: 29320401
Circ Heart Fail. 2021 Jan;14(1):e007275
pubmed: 33464957
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):83-8
pubmed: 25474016
J Am Coll Cardiol. 2018 Aug 14;72(7):721-733
pubmed: 30092948
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1023-30
pubmed: 15105281
Circulation. 1998 Nov 3;98(18):1842-7
pubmed: 9799202
J Am Heart Assoc. 2020 Jun 2;9(11):e016055
pubmed: 32458724
Nat Med. 2016 Dec;22(12):1428-1438
pubmed: 27841876
J Mol Cell Cardiol. 2012 Sep;53(3):392-400
pubmed: 22705145
J Nutr. 2008 Sep;138(9):1746S-1751S
pubmed: 18716180
J Am Heart Assoc. 2015 May 28;4(6):e001833
pubmed: 26021436
Nutr Metab Cardiovasc Dis. 2015 Jan;25(1):60-7
pubmed: 25315667
Atherosclerosis. 2010 Feb;208(2):518-23
pubmed: 19700158
Eur Heart J. 2005 Jun;26(11):1115-40
pubmed: 15901669
Int J Epidemiol. 2012 Apr;41(2):377-85
pubmed: 21172932
Int J Cardiol. 2014 Feb 15;171(3):368-76
pubmed: 24398230
J Mol Med (Berl). 2020 Jul;98(7):999-1008
pubmed: 32504111
Am J Cardiol. 2019 Jun 15;123(12):1955-1961
pubmed: 30979411
Biometrics. 1984 Mar;40(1):63-75
pubmed: 6375751
Int J Cardiol. 2016 Jan 15;203:640-6
pubmed: 26580348
Biomolecules. 2018 Aug 30;8(3):
pubmed: 30200232
Eur J Heart Fail. 2010 Dec;12(12):1274-81
pubmed: 20923854
Glob J Health Sci. 2012 Sep 28;4(6):170-8
pubmed: 23121753
Amino Acids. 2017 Jan;49(1):173-182
pubmed: 27796501
Biomed Res Int. 2020 Jul 04;2020:6960107
pubmed: 32714983
Arterioscler Thromb Vasc Biol. 2019 May;39(5):869-875
pubmed: 30866658
J Am Heart Assoc. 2016 Apr 13;5(4):e002565
pubmed: 27076564
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Med Sci Sports Exerc. 2000 Aug;32(8):1431-7
pubmed: 10949009
Am J Epidemiol. 1994 Jun 15;139(12):1197-209
pubmed: 8209878
Curr Opin Clin Nutr Metab Care. 2020 Jan;23(1):35-50
pubmed: 31688095
Atherosclerosis. 2014 Sep;236(1):7-17
pubmed: 24998934
J Am Coll Cardiol. 2016 Dec 27;68(25):2850-2870
pubmed: 28007146
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
Circulation. 2018 Feb 20;137(8):841-853
pubmed: 29459470
J Proteome Res. 2019 Mar 1;18(3):1446-1450
pubmed: 30562035
Eur J Heart Fail. 2017 Sep;19(9):1179-1185
pubmed: 28133855
Int J Epidemiol. 2014 Feb;43(1):187-201
pubmed: 24585856
Amino Acids. 2014 Oct;46(10):2271-86
pubmed: 25161088
Circulation. 2014 Jul 1;130(1):18-26
pubmed: 24787471
Am Heart J. 2016 Jun;176:100-6
pubmed: 27264226
J Nutr. 2016 Dec;146(12):2579S-2586S
pubmed: 27934648
Eur Heart J. 2009 May;30(9):1142-50
pubmed: 19297385